Cortisol Myths Debunked: What Healthcare Professionals Should Know

Executive Summary

Cortisol has become the internet’s most blamed hormone, charged with causing belly fat, puffy faces, fatigue, insomnia, anxiety, and nearly every midlife inconvenience. Patients arrive in the clinic convinced that their cortisol is too high, too low, or too something, often after watching a TikTok video and buying a supplement bundle. This post examines eight of the most consequential cortisol myths circulating in popular media through the lens of peer-reviewed endocrinology, psychoneuroendocrinology, and behavioral medicine.

The central message is not that cortisol is irrelevant. It is that cortisol is rhythmic, context-dependent, and clinically meaningful only when interpreted in light of timing, symptoms, medications, comorbidities, and validated testing. Cortisol supports arousal, blood pressure regulation, glucose availability, immune balance, and survival itself. The risk emerges when secretion is excessive, deficient, poorly timed, pharmacologically altered, or uncoupled from normal feedback.

For healthcare providers, the practical task is to replace cortisol panic with endocrine literacy. Patients who worry about cortisol often carry genuine distress: poor sleep, trauma history, burnout, pain, metabolic worry, or medication side effects. The clinician’s job is to validate the suffering without validating a false diagnosis. Effective care means screening for red flags, gently discouraging unvalidated testing and supplements, coordinating with primary care or endocrinology when indicated, and treating the modifiable drivers that actually move the needle.

The best clinical stance is neither dismissal nor endocrine alarmism. It is disciplined curiosity. Cortisol can be a biomarker, a mechanism, a medication effect, or a distraction. The distinction matters because mislabeling ordinary distress as high cortisol can divert patients from evidence-based care, while missing Cushing's syndrome or adrenal insufficiency can be dangerous.

Why Cortisol Became the Internet’s Favorite Villain

The popular phrase stress hormone is accurate but incomplete. Cortisol is a steroid hormone produced mainly by the adrenal cortex, the outer layer of the adrenal glands that sit above the kidneys. It helps maintain blood pressure, mobilize glucose, regulate inflammation, influence memory consolidation, and coordinate wakefulness with daily energy demands (Sapolsky, Romero, & Munck, 2000). Calling it merely a stress hormone is like calling oxygen a fire accelerant. The statement is true in one context and badly misleading in another.

The endocrine system does not organize itself around moral categories. Cortisol is not inherently toxic, and the goal of care is not to suppress it as much as possible. The clinical question is whether cortisol is appropriately timed, proportionate to demand, and regulated by feedback. That reframe matters because most patients have been taught to fear a hormone they actually need.

The system that regulates cortisol is the hypothalamic-pituitary-adrenal axis, often shortened to the HPA axis. The hypothalamus releases corticotropin-releasing hormone, the pituitary releases adrenocorticotropic hormone, and the adrenal cortex releases cortisol.

Cortisol then feeds back to the brain and pituitary to help restrain further output. This negative feedback loop is one reason simplistic boost-or-detox narratives do not map well onto biology (Lightman, Birnie, & Conway-Campbell, 2020).

For clinicians, the first reframe is simple. Patients should not be taught to fear cortisol. They should be taught to understand rhythm, recovery, and context. That reframe reduces shame and opens more useful conversations about sleep, trauma, metabolic health, medication use, and behavioral patterns that keep the stress system switched on.

Myth 1: Is Cortisol Basically Poison Your Body Makes on Its Own?

This is the foundational myth that props up every other cortisol panic. It confuses a hormone’s role during stress with the idea that the hormone itself is harmful. In normal physiology, cortisol is adaptive. It helps the body meet energetic demands, supports vascular tone, and shapes immune activity so inflammatory responses do not run unchecked (Sapolsky, Romero, & Munck, 2000). A person with no cortisol does not feel calm. A person with no cortisol is in a medical crisis.

The partial truth is that sustained or excessive glucocorticoid exposure can be damaging. Hypercortisolism, meaning pathologically excessive cortisol exposure, can contribute to hypertension, insulin resistance, osteoporosis, muscle wasting, mood symptoms, immune vulnerability, and central fat accumulation.

This is most visible in Cushing's syndrome, a disorder caused by chronic glucocorticoid excess from endogenous production or exogenous steroid exposure (Fleseriu et al., 2021; Nieman et al., 2008).

The opposite problem is equally serious and often forgotten. Adrenal insufficiency refers to inadequate cortisol production or action, which may cause fatigue, weight loss, hypotension, hyponatremia, hypoglycemia, and potentially life-threatening adrenal crisis.

Addison's disease is primary adrenal insufficiency, often autoimmune in industrialized settings. A patient with too little cortisol does not need a detox. The patient needs prompt medical evaluation and, when confirmed, glucocorticoid replacement.

Clinically, swap the myth for a balance statement: cortisol is essential, but abnormal exposure is harmful. That sentence protects patients from two errors. It prevents fear-driven self-treatment, and it keeps clinicians alert to genuine endocrine disease when signs are progressive, multisystemic, and disproportionate to ordinary life stress.

Myth 2: Is the Goal to Get Your Cortisol as Low as Possible?

A low-is-better cortisol goal misreads the architecture of endocrine time. Cortisol follows a daily rhythm. It rises during late night and early morning, jumps sharply after waking, and then declines throughout the day toward a nighttime low (Lightman, Birnie, & Conway-Campbell, 2020; Stalder, Oster, Abelson, Huthsteiner, Klucken, & Clow, 2025). A high morning value may be perfectly normal, while the same value measured at midnight can be a warning sign.

The morning rise is called the cortisol awakening response, a rapid increase in cortisol during the first 30 to 45 minutes after awakening. It is not merely a stress spike. It appears to prepare the organism for the expected demands of the day and supports cognitive and emotional readiness for the upcoming day (Clow, Hucklebridge, Stalder, Evans, & Thorn, 2010; Stalder, Oster, Abelson, Huthsteiner, Klucken, & Clow, 2025). It is influenced by sleep timing, light exposure, anticipation, health status, and sampling compliance.

The decline from morning to evening is often summarized as the diurnal cortisol slope. A flatter slope, especially when evening cortisol is relatively high or morning cortisol is relatively low, has been associated with poorer physical and mental health outcomes across studies (Adam, Quinn, Tavernier, McQuillan, Dahlke, & Gilbert, 2017).

Average effects are modest, and methods vary, but the signal is clinically plausible, as a flattened rhythm may reflect impaired coordination among arousal, recovery, sleep, and immune regulation.

The clinical lesson is that timing is not a nuisance variable. It is part of the diagnosis. A random cortisol value collected without consideration of waking time, shift work, medications, pregnancy, estrogen exposure, illness, or acute stress carries little meaning. Healthcare providers should actively discourage patients from interpreting cortisol as a single number on a number line and teach them to think in terms of curves rather than points.

Myth 3: Can Patients Actually Feel Their Cortisol Rising in Real Time?

Patients often report feeling their cortisol levels climbing. What they usually feel is sympathetic arousal: palpitations, tremor, sweating, chest tightness, breathlessness, muscle tension, or gastrointestinal churning. Those sensations are more closely linked to catecholamines such as adrenaline and noradrenaline than to cortisol itself. Cortisol changes unfold over minutes to hours, not as second-by-second body weather.

The partial truth is that cortisol can influence mood, cognition, energy, appetite, sleep, and threat processing. It interacts with the amygdala, hippocampus, and prefrontal cortex, as well as immune signaling and metabolic pathways. Those effects, however, are nonspecific. A fatigued, anxious, sleep-deprived patient cannot infer cortisol status from subjective experience alone, and neither can their wearable device.

This distinction matters enormously in psychotherapy. When patients label every wave of distress as cortisol, they can become hypervigilant toward bodily sensations. That vigilance often amplifies anxiety and reinforces avoidance. A more helpful intervention is psychoeducation: your body is mobilizing, and that does not prove endocrine damage. This preserves the patient’s lived experience while gently correcting the attribution.

Clinicians can also redirect tracking behaviors productively. Rather than encouraging patients to monitor facial puffiness, momentary anxiety, or wearable stress scores as proxies for cortisol, ask them to track sleep timing, alcohol intake, caffeine timing, avoidance behaviors, pain flares, activity, menstrual phase when relevant, and medication changes. Those variables are more actionable and less likely to produce endocrine catastrophizing.

Myth 4: Is That Puffy Face in the Mirror “Cortisol Face”?

The internet phrase "cortisol face" usually refers to a puffy or rounded face attributed to everyday stress.

The medical phenomenon behind the phrase is real, but much narrower than the trend suggests. In Cushing syndrome, chronic glucocorticoid excess can produce facial rounding, dorsocervical fat accumulation, supraclavicular fullness, proximal muscle weakness, wide purple striae, easy bruising, menstrual changes, hypertension, and glucose intolerance (Fleseriu et al., 2021; Nieman et al., 2008).

The myth lives in the timeline and specificity. Cushing's-like facial changes develop gradually, almost always with other progressive signs. They are not a reliable explanation for day-to-day changes in facial appearance. Short-term puffiness is more plausibly related to sleep loss, salt intake, alcohol, menstrual cycle effects, crying, allergies, medications, or simple fluid shifts.

The clinical task is to avoid both trivialization and overdiagnosis. When a patient shows progressive central weight gain, proximal weakness, new hypertension, worsening diabetes, easy bruising, wide violaceous striae, osteoporosis, or adrenal incidentaloma, endocrine evaluation is appropriate. When the only symptom is transient facial fullness after a bad night's sleep, the clinician should normalize variability and assess lifestyle factors.

Mental health clinicians should also recognize the body-image risk embedded in cortisol face content. Viral appearance comparisons can intensify appearance checking and shame, which is especially concerning in patients with eating disorders, body dysmorphic concerns, health anxiety, or obsessive-compulsive traits. Cortisol narratives may become another compulsive explanation for normal bodily fluctuation, and clinicians should treat this pattern the way they would treat any harmful checking behavior.

Myth 5: Does Chronic Stress Really Mean Chronically High Cortisol?

This is perhaps the most intuitive cortisol myth, and it is often wrong. The acute stress response can raise cortisol, especially when a stressor is socially evaluative, uncontrollable, novel, or threatening. Laboratory paradigms such as the Trier Social Stress Test demonstrate measurable cortisol increases, but responses vary substantially by sex, age, menstrual phase, medications, psychiatric status, and protocol details (Goodman, Janson, & Wolf, 2017; Zorn, Schur, Boks, Kahn, Joels, & Vinkers, 2017).

Chronic stress is messier. Some chronic stress states are associated with elevated cortisol output, some with flattened rhythms, some with blunted reactivity, and some with lower morning output.

Hypocortisolism, meaning unusually low cortisol activity in context, has been described in chronic fatigue, posttraumatic stress, burnout, and some pain conditions, although findings are inconsistent (Chida & Steptoe, 2009; Kudielka, Bellingrath, & Hellhammer, 2006). The same environmental pressure can, across patients and across time, push the system in different directions.

This is especially clear in posttraumatic stress disorder, which does not fit the simple high-cortisol model. The most consistent neuroendocrine pattern in PTSD includes lower basal cortisol output, enhanced glucocorticoid receptor sensitivity, altered feedback, and blunted stress reactivity, although the lower-cortisol effect is conditional, appearing most reliably in certain subgroups and sampling windows rather than uniformly across patients (Meewisse, Reitsma, de Vries, Gersons, & Olff, 2007; Olff & van Zuiden, 2017; Rohleder, Joksimovic, Wolf, & Kirschbaum, 2004).

PTSD has been associated in multiple studies with lower basal cortisol, enhanced glucocorticoid receptor sensitivity, altered feedback, and abnormal stress reactivity (Olff & van Zuiden, 2017; Rohleder, Joksimovic, Wolf, & Kirschbaum, 2004). The glucocorticoid receptor is the intracellular receptor through which cortisol influences gene transcription and cellular function, and receptor sensitivity can matter as much as hormone concentration.

This is where allostatic load becomes a more useful frame than simple high cortisol. Allostatic load refers to cumulative wear and tear from repeated adaptation to stressors. It does not require any single hormone to remain high at all times. A patient may show sleep fragmentation, inflammation, autonomic hyperarousal, pain sensitization, substance use, and avoidance even when a single cortisol measurement looks normal.

For healthcare professionals, this nuance is protective. Patients who believe chronic stress must equal high cortisol often pursue unnecessary supplements or panels. Clinicians can instead explain that chronic threat changes sleep, behavior, inflammation, autonomic tone, mood, and health habits. Cortisol may participate in any of these pathways, but it is not the only mechanism and may not move in the direction patients expect.

Myth 6: Does “Adrenal Fatigue” Explain Burnout, Brain Fog, and Exhaustion?

The term adrenal fatigue is marketed as the idea that chronic stress exhausts the adrenal glands until they can no longer produce enough cortisol. It is compelling. It is also not a recognized endocrine diagnosis, and a systematic review of 58 studies concluded that adrenal fatigue is not substantiated as a medical condition (Cadegiani & Kater, 2016). The Endocrine Society has been equally direct: there is no scientific proof that adrenal fatigue is a true medical condition (Endocrine Society, 2022).

The myth is powerful because the symptoms are real. Fatigue, brain fog, low motivation, salt cravings, low mood, dizziness, and nonrestorative sleep deserve attention. The error is assigning them to an unvalidated adrenal mechanism before evaluating more likely causes. These include insomnia, obstructive sleep apnea, depression, anxiety disorders, anemia, thyroid disease, medication effects, alcohol use, chronic pain, inflammatory disease, perimenopause, undernutrition, overtraining, and the entity this myth is often mistaken for: genuine burnout, a work-related syndrome involving exhaustion, mental distance from work, and reduced professional efficacy.

This is an ideal place for empathic correction. Telling a patient that adrenal fatigue is fake can sound like your suffering is fake. A better formulation is this: fatigue is real, but the adrenal fatigue explanation has not held up scientifically, so let us look for causes we can actually test and treat. That sentence respects the symptom while retiring the label.

Action should be collaborative triage. Mental health providers can screen for sleep duration, sleep apnea symptoms, depression, anxiety, trauma exposure, substance use, and medication changes. They can recommend a primary care evaluation when fatigue is persistent, progressive, or accompanied by weight loss, syncope, hyperpigmentation, orthostatic symptoms, fever, abnormal bleeding, or other medical red flags. The goal is to redirect rabbit-hole supplement spending into a targeted workup that can actually help.

Myth 7: Will Ashwagandha and Adaptogens Reliably Fix Your Cortisol?

The term adaptogens refers to herbs or compounds marketed as improving the body’s resistance to stress. Ashwagandha (Withania somnifera) is the best-known cortisol-related example, and the evidence is not empty.

Recent systematic reviews and meta-analyses of randomized trials do report statistically significant reductions in perceived stress, anxiety, and serum cortisol, typically at doses of 250 to 600 mg daily over 8 to 12 weeks (Arumugam et al., 2024; Bachour, Samir, Haddad, Houssaini, & El Radad, 2025).

The nuance is that a modest reduction in cortisol in a short-duration trial does not mean ashwagandha corrects a cortisol disorder. A more recent meta-analysis found that ashwagandha significantly lowered cortisol but did not reduce perceived stress on the Perceived Stress Scale, suggesting that the biomarker and lived experience do not always move in tandem (Albalawi, 2025). Long-term safety, product standardization, liver-risk signals, drug interactions, pregnancy safety, and use in autoimmune or thyroid disease remain open clinical concerns.

The supplement category also carries a more concrete risk. An analysis of over-the-counter adrenal support products found that all 12 products contained detectable thyroid hormone and most contained at least one steroid hormone, despite these ingredients not being disclosed on the labels (Akturk, Chindris, Hines, Singh, & Bernet, 2018). That finding matters because hidden steroid or thyroid exposure can worsen anxiety, insomnia, hypertension, glucose control, bone health, and endocrine feedback, sometimes dramatically.

Clinical advice should be direct but not dismissive. Do not tell patients that no supplement can ever affect stress physiology. Tell them that cortisol-lowering claims are often exaggerated, products are variably regulated, and some may contain biologically active hormones they did not knowingly consume. Patients taking adrenal, thyroid-support, cortisol-management, or bodybuilding products should be asked to bring bottles or ingredient lists to their next medical visit.

Myth 8: Can an At-Home Cortisol Test Tell You What’s Wrong?

At-home testing appeals to patients because it offers a number when symptoms feel confusing. Cortisol is, unfortunately, one of the worst hormones to interpret casually. It varies by time of day, waking time, sleep quality, acute stress, illness, pain, shift work, pregnancy, estrogen therapy, oral contraceptives, alcohol, depression, glucocorticoid medications, and sampling adherence. A single value ripped out of that context is less like a diagnostic finding and more like a photograph of a weather pattern taken through a pinhole.

Validated endocrine testing is different from wellness screening. For suspected Cushing syndrome, guidelines recommend tests with known diagnostic performance, such as late-night salivary cortisol, 24-hour urinary free cortisol, or the dexamethasone suppression test, after excluding exogenous glucocorticoid exposure and considering pretest probability (Fleseriu et al., 2021; Nieman et al., 2008). The dexamethasone suppression test examines whether administered dexamethasone appropriately suppresses cortisol production through feedback inhibition, which is the point at which most Cushing cases reveal themselves.

Even validated tests can mislead. Depression, alcohol use disorder, severe obesity, poorly controlled diabetes, and acute illness can produce pseudo-Cushing states, meaning biochemical or clinical features that resemble Cushing syndrome without autonomous cortisol excess. Some patients have cyclic Cushing's syndrome, in which cortisol excess fluctuates and repeated testing may be needed. A single normal result does not always rule out disease when clinical suspicion is high.

Meanwhile, hair cortisol concentration can estimate longer-term cortisol exposure across weeks to months and is valuable in research settings. Hair treatment, washing, pigmentation, growth rate, assay methods, and population differences complicate individual clinical interpretation, though. Systematic reviews support hair cortisol as a promising chronic-stress biomarker, but not as a standalone consumer diagnostic tool (Li, Li, Zhu, Cohen, & Chen, 2023; Russell, Koren, Rieder, & Van Uum, 2012).

The clinical message is that cortisol testing is powerful when used correctly and misleading when used randomly. Patients can be invited to bring any test results to a physician rather than repeatedly purchasing new panels that reset the anxiety clock. The goal is to close rabbit holes, not to win arguments about hormones.

Clinical Red Flags Worth Escalating

Mental health providers do not need to diagnose endocrine disease, but they should know when to refer. Concern for Cushing syndrome rises when symptoms are progressive, clustered, and discriminatory. Findings such as proximal muscle weakness, easy bruising, wide purple striae, facial plethora, osteoporosis at a young age, unexplained severe hypertension, early-onset diabetes, adrenal incidentaloma, or rapid central weight gain deserve medical evaluation rather than reassurance.

Concern for adrenal insufficiency rises with unexplained weight loss, persistent hypotension, orthostatic dizziness, salt craving, recurrent nausea or abdominal pain, hyperpigmentation, hyponatremia, hypoglycemia, or a history of chronic glucocorticoid exposure. Abrupt discontinuation of oral, injected, inhaled, topical, or intra-articular steroids can suppress the HPA axis. Exogenous glucocorticoids are steroid medications or hormone-like exposures from outside the body, and they are among the most common causes of clinically significant cortisol dysregulation.

The term "steroid" should be interpreted broadly during history-taking. Ask about prednisone, methylprednisolone dose packs, steroid joint injections, inhalers, topical creams, nasal sprays, bodybuilding products, adrenal support products, and compounded hormone preparations. Patients rarely volunteer these exposures because they do not think of nasal sprays or creams when their clinician asks about medications.

Referral language should be calm. Say something like this: most cortisol worries do not turn out to be endocrine disease, but your pattern has a few features worth checking medically. That formulation avoids both false reassurance and alarm that could intensify anxiety, and it frames referral as thoroughness rather than escalation.

Actionable Steps for Healthcare Professionals

Begin with validation and reframing. Patients who arrive with cortisol concerns often feel dismissed by clinicians and frightened by online content. A useful opening sounds like this: cortisol is real and important, but most online explanations of cortisol are too simplistic, so let us separate endocrine red flags from stress-system patterns we can actually treat. This stance lets patients maintain their curiosity while alleviating their panic.

Assess sleep first. Sleep restriction, irregular schedules, nightmares, insomnia, obstructive sleep apnea, evening alcohol, and shift work all disrupt the same arousal systems patients attribute to cortisol. Behavioral sleep medicine, cognitive behavioral therapy for insomnia, nightmare treatment, and circadian regularity are typically more powerful than hormone tracking and have better evidence behind them.

Treat avoidance and threat persistence. When anxiety, trauma, or chronic interpersonal stress keeps the patient in defensive preparation mode, the target is not cortisol suppression. The targets are safety learning, emotion regulation, exposure when appropriate, boundary work, problem-solving, and restoration of rewarding routines. Cortisol will often normalize as life becomes less organized around threat.

Coordinate medical care when needed. Encourage primary-care evaluation for persistent fatigue, unexplained weight change, new hypertension, glucose abnormalities, syncope, menstrual disruption, or medication concerns. Refer to endocrinology when the pattern suggests Cushing syndrome, adrenal insufficiency, pituitary disease, adrenal incidentaloma, or complex steroid exposure.

Review supplements and online protocols without shaming the patient. Ask specifically about adrenal products, cortisol managers, thyroid support, ashwagandha, licorice, DHEA, and bodybuilding supplements.

Dehydroepiandrosterone, or DHEA, is an adrenal androgen precursor sometimes marketed for energy or anti-aging. It can alter hormone exposure and should not be treated as benign just because it is sold over the counter.

Use behavioral physiology as the bridge. Slow breathing, heart rate variability biofeedback, relaxation training, mindfulness, graded exercise, social rhythm stabilization, and values-based activity do not need to be sold as cortisol hacks. They are legitimate ways to reduce autonomic arousal, improve sleep, increase agency, and support recovery. That language is more accurate and more durable than promising hormonal control.

Integrative Summary

Cortisol myths thrive because they attach a simple endocrine story to symptoms that are common, distressing, and medically ambiguous. Fatigue, weight change, anxiety, insomnia, brain fog, and facial puffiness are all real experiences that deserve real attention. The problem is not patient concern. The problem is premature certainty.

The best evidence supports a far more textured model. Cortisol is essential for life, follows a circadian rhythm, responds to acute challenge, and participates in metabolic, immune, cognitive, and emotional regulation. Chronic stress can alter cortisol dynamics, but not in one uniform direction. Psychiatric disorders do not have a single cortisol fingerprint, and consumer tests cannot replace clinical reasoning.

For healthcare providers, the practical goal is to help patients move from a fear of cortisol to stress-system literacy. That means recognizing endocrine red flags, avoiding false diagnoses, treating sleep and behavioral drivers, reviewing medications and supplements, and coordinating care when medical testing is warranted. The result is more precise, more compassionate, and more clinically useful than the internet’s cortisol panic.

Five Takeaways

1. Cortisol is essential, not inherently harmful; pathology depends on dose, timing, duration, feedback regulation, and clinical context.

2. A single cortisol value rarely explains fatigue, anxiety, weight gain, or poor sleep; rhythm and pretest probability are what matter most.

3. Chronic stress can produce high, low, flattened, or blunted cortisol patterns, which means stress equals high cortisol is too simple to be useful clinically.

4. Adrenal fatigue is not a validated diagnosis, but the symptoms attributed to it deserve careful medical and psychological assessment that actually leads somewhere.

5. The safest clinical approach is to validate distress, screen for red flags, discourage unvalidated tests and supplements, and treat modifiable sleep, behavioral, metabolic, and trauma-related drivers.

Glossary

acute stress response: the coordinated physiological reaction to immediate challenge or threat, involving autonomic, endocrine, immune, and behavioral systems.

adaptogens: substances, usually herbs, marketed as improving resistance to stress, though clinical evidence and product standardization vary.

Addison's disease: primary adrenal insufficiency, often autoimmune, in which the adrenal cortex produces inadequate cortisol and often inadequate aldosterone.

adrenal fatigue: an unvalidated diagnosis claiming that chronic stress exhausts the adrenal glands, despite lack of scientific substantiation.

adrenal insufficiency: inadequate cortisol production or action, which may cause fatigue, hypotension, weight loss, electrolyte abnormalities, and adrenal crisis.

allostatic load: cumulative physiological strain from repeated or prolonged adaptation to stressors.

ashwagandha: an herbal product from Withania somnifera marketed for stress and anxiety, with some trial evidence but important limitations and safety questions.

burnout: a work-related syndrome involving exhaustion, mental distance or cynicism, and reduced professional efficacy.

cortisol: a glucocorticoid hormone produced by the adrenal cortex that helps regulate metabolism, blood pressure, inflammation, arousal, and stress adaptation.

cortisol awakening response: the rapid increase in cortisol that typically occurs during the first 30 to 45 minutes after awakening.

Cushing's syndrome: a disorder caused by chronic glucocorticoid excess from endogenous cortisol production or exogenous steroid exposure.

cyclic Cushing's syndrome: a form of Cushing's syndrome in which cortisol excess fluctuates, sometimes producing normal test results between active phases.

dehydroepiandrosterone (DHEA): an adrenal androgen precursor sometimes sold as a supplement for energy, aging, or hormone support.

dexamethasone suppression test: a diagnostic test assessing whether dexamethasone appropriately suppresses cortisol production through feedback inhibition.

diurnal cortisol slope: the pattern of cortisol decline from morning to evening across the day.

exogenous glucocorticoids: steroid medications or hormone-like exposures that come from outside the body and can alter HPA-axis function.

glucocorticoid receptor: the intracellular receptor through which cortisol and related steroid hormones influence gene expression and cellular function.

hair cortisol concentration: a research biomarker estimating longer-term cortisol exposure from cortisol incorporated into growing hair.

hypercortisolism: excessive cortisol exposure, which may be endogenous or caused by glucocorticoid medications.

hypocortisolism: unusually low cortisol activity in a given context, which may reflect adrenal insufficiency or altered stress-system regulation.

hypothalamic-pituitary-adrenal axis: the endocrine system linking hypothalamus, pituitary gland, and adrenal cortex to regulate cortisol secretion.

late-night salivary cortisol: a screening test for Cushing's syndrome that evaluates whether cortisol is inappropriately elevated when it should be low.

negative feedback: a regulatory process in which a hormone signal reduces further production of that hormone through upstream control centers.

pseudo-Cushing's states: non-Cushing's conditions, such as severe depression or alcohol use disorder, that may mimic some biochemical or clinical features of Cushing syndrome.

24-hour urinary free cortisol: a screening test that estimates total unbound cortisol excreted in urine over a full day.

References

Adam, E. K., Quinn, M. E., Tavernier, R., McQuillan, M. T., Dahlke, K. A., & Gilbert, K. E. (2017). Diurnal cortisol slopes and mental and physical health outcomes: A systematic review and meta-analysis. Psychoneuroendocrinology, 83, 25–41. https://doi.org/10.1016/j.psyneuen.2017.05.018

Akturk, H. K., Chindris, A. M., Hines, J. M., Singh, R. J., & Bernet, V. J. (2018). Over-the-counter “adrenal support” supplements contain thyroid and steroid-based adrenal hormones. Mayo Clinic Proceedings, 93(3), 284–290. https://doi.org/10.1016/j.mayocp.2017.10.019

Albalawi, A. A. (2025). Dual impact of ashwagandha: Significant cortisol reduction but no effects on perceived stress—A systematic review and meta-analysis. Nutrition and Health, 31(4), 1395–1408. https://doi.org/10.1177/02601060251363647

Arumugam, V., Vijayakumar, V., Balakrishnan, A., Bhandari, R. B., Boopalan, D., Ponnurangam, R., Sankaralingam Thirupathy, V., & Kuppusamy, M. (2024). Effects of ashwagandha (Withania somnifera) on stress and anxiety: A systematic review and meta-analysis. Explore, 20(6), 103062. https://doi.org/10.1016/j.explore.2024.103062

Bachour, G., Samir, A., Haddad, S., Houssaini, M. A., & El Radad, M. (2025). Effects of ashwagandha supplements on cortisol, stress, and anxiety levels in adults: A systematic review and meta-analysis. BJPsych Open, 11(S1), S39. https://doi.org/10.1192/bjo.2025.10136

Cadegiani, F. A., & Kater, C. E. (2016). Adrenal fatigue does not exist: A systematic review. BMC Endocrine Disorders, 16, 48. https://doi.org/10.1186/s12902-016-0128-4

Chida, Y., & Steptoe, A. (2009). Cortisol awakening response and psychosocial factors: A systematic review and meta-analysis. Biological Psychology, 80(3), 265–278. https://doi.org/10.1016/j.biopsycho.2008.10.004

Clow, A., Hucklebridge, F., Stalder, T., Evans, P., & Thorn, L. (2010). The cortisol awakening response: More than a measure of HPA axis function. Neuroscience and Biobehavioral Reviews, 35(1), 97–103. https://doi.org/10.1016/j.neubiorev.2009.12.011

Endocrine Society. (2022). Adrenal fatigue. https://www.endocrine.org/patient-engagement/endocrine-library/adrenal-fatigue

Fleseriu, M., Auchus, R., Bancos, I., Ben-Shlomo, A., Bertherat, J., Biermasz, N. R., Boguszewski, C. L., Bronstein, M. D., Buchfelder, M., Carmichael, J. D., Casanueva, F. F., Castinetti, F., Chanson, P., Findling, J., Gadelha, M., Geer, E. B., Giustina, A., Grossman, A., Gurnell, M., … Biller, B. M. K. (2021). Consensus on diagnosis and management of Cushing’s disease: A guideline update. The Lancet Diabetes & Endocrinology, 9(12), 847–875. https://doi.org/10.1016/S2213-8587(21)00235-7

Goodman, W. K., Janson, J., & Wolf, J. M. (2017). Meta-analytical assessment of the effects of protocol variations on cortisol responses to the Trier Social Stress Test. Psychoneuroendocrinology, 80, 26–35. https://doi.org/10.1016/j.psyneuen.2017.02.030

Kudielka, B. M., Bellingrath, S., & Hellhammer, D. H. (2006). Cortisol in burnout and vital exhaustion: An overview. Giornale Italiano di Medicina del Lavoro ed Ergonomia, 28(1, Suppl. 1), 34–42.

Li, Y., Li, Y., Zhu, X., Cohen, S., & Chen, X. (2023). Associations between chronic stress and hair cortisol in children: A systematic review and meta-analysis. Journal of Affective Disorders, 324, 508–517. https://doi.org/10.1016/j.jad.2022.12.065

Lightman, S. L., Birnie, M. T., & Conway-Campbell, B. L. (2020). Dynamics of ACTH and cortisol secretion and implications for disease. Endocrine Reviews, 41(3), 470–490. https://doi.org/10.1210/endrev/bnaa002

Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008). The diagnosis of Cushing’s syndrome: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 93(5), 1526–1540. https://doi.org/10.1210/jc.2008-0125

Olff, M., & van Zuiden, M. (2017). Neuroendocrine and neuroimmune markers in PTSD: Pre-, peri-, and post-trauma glucocorticoid and inflammatory dysregulation. Current Opinion in Psychology, 14, 132–137. https://doi.org/10.1016/j.copsyc.2017.01.001

Rohleder, N., Joksimovic, L., Wolf, J. M., & Kirschbaum, C. (2004). Hypocortisolism and increased glucocorticoid sensitivity of pro-inflammatory cytokine production in Bosnian war refugees with posttraumatic stress disorder. Biological Psychiatry, 55(7), 745–751. https://doi.org/10.1016/j.biopsych.2003.11.018

Russell, E., Koren, G., Rieder, M., & Van Uum, S. (2012). Hair cortisol as a biological marker of chronic stress: Current status, future directions and unanswered questions. Psychoneuroendocrinology, 37(5), 589–601. https://doi.org/10.1016/j.psyneuen.2011.09.009

Sapolsky, R. M., Romero, L. M., & Munck, A. U. (2000). How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocrine Reviews, 21(1), 55–89. https://doi.org/10.1210/edrv.21.1.0389

Stalder, T., Oster, H., Abelson, J. L., Huthsteiner, K., Klucken, T., & Clow, A. (2025). The cortisol awakening response: Regulation and functional significance. Endocrine Reviews, 46(1), 43–59. https://doi.org/10.1210/endrev/bnae024

Zorn, J. V., Schur, R. R., Boks, M. P., Kahn, R. S., Joëls, M., & Vinkers, C. H. (2017). Cortisol stress reactivity across psychiatric disorders: A systematic review and meta-analysis. Psychoneuroendocrinology, 77, 25–36. https://doi.org/10.1016/j.psyneuen.2016.11.036

About the Author

Fred Shaffer earned his PhD in Psychology from Oklahoma State University. He earned BCIA certifications in Biofeedback and HRV Biofeedback. Fred is an Allen Fellow and Professor of Psychology at Truman State University, where he has taught for 50 years. He is a Biological Psychologist who consults and lectures in heart rate variability biofeedback, Physiological Psychology, and Psychopharmacology. Fred helped to edit Evidence-Based Practice in Biofeedback and Neurofeedback (3rd and 4th eds.) and helps to maintain BCIA's certification programs. He is a recipient of AAPB's Distinguished Scientist Award and BFE's Lifetime Impact Award.

Support Our Friends

Cortisol Myths Debunked_ What Healthcare Professionals Should Know.pdf

Download PDF • 18.02MB